The reiteration of a Buy rating and a $10 price target by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could positively influence Compass Therapeutics' stock price in the short term. Analyst ratings, especially from well-regarded firms, often impact investor sentiment and can lead to price movements.